14;186:E391-8.
90. Welch HJ, Schul MW, Monahan DL, et al. Private payersâ€™ varicose vein
policies are inaccurate, disparate, and not evidence based, which
mandates a proposal for a reasonable and responsible policy for the
treatment of venous disease. J Vasc Surg Venous Lymphat Disord
2021;9:820-32.
91. Marsden G, Perry M, Bradbury A, et al. A cost-effectiveness analysis
of surgery, endothermal ablation, ultrasound-guided foam sclerotherapy and compression stockings for symptomatic varicose veins.
Eur J Vasc Endovasc Surg 2015;50:794-801.
92. Michaels JA, Campbell WB, Brazier JE, et al. Randomised clinical
trial, observational study and assessment of cost-effectiveness of
the treatment of varicose veins (REACTIV trial). Health Technol
Assess 2006;10:1-196. iii-iv.
93. Al Shakarchi J, Wall M, Newman J, et al. The role of compression
after endovenous ablation of varicose veins. J Vasc Surg Venous
Lymphat Disord 2018;6:546-50.
94. Ayo D, Blumberg SN, Rockman CR, et al. Compression versus No
compression after endovenous ablation of the great saphenous
vein: a randomized controlled trial. Ann Vasc Surg 2017;38:72-7.
95. Hamann SAS, Timmer-de Mik L, Fritschy WM, Kuiters GRR,
Nijsten TEC, van den Bos RR. Randomized clinical trial of endovenous laser ablation versus direct and indirect radiofrequency ablation for the treatment of great saphenous varicose veins. Br J Surg
2019;106:998-1004.
96. Nordon IM, Hinchliffe RJ, Brar R, et al. A prospective double-blind
randomized controlled trial of radiofrequency versus laser treatment of the great s